Annual Non Current Assets
$52.79 M
+$43.47 M+466.39%
December 31, 2023
Summary
- As of February 7, 2025, AMLX annual long term assets is $52.79 million, with the most recent change of +$43.47 million (+466.39%) on December 31, 2023.
- During the last 3 years, AMLX annual non current assets has risen by +$52.32 million (+11252.26%).
- AMLX annual non current assets is now at all-time high.
Performance
AMLX Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Non Current Assets
$5.45 M
+$10.00 K+0.18%
September 30, 2024
Summary
- As of February 7, 2025, AMLX quarterly long term assets is $5.45 million, with the most recent change of +$10.00 thousand (+0.18%) on September 30, 2024.
- Over the past year, AMLX quarterly non current assets has dropped by -$27.02 million (-83.22%).
- AMLX quarterly non current assets is now -89.68% below its all-time high of $52.79 million, reached on December 31, 2023.
Performance
AMLX Quarterly Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Non Current Assets Formula
Non Current Assets = Property, Plant, and Equipment + Intangible Assets + Long-Term Investments + Deferred Tax Assets + Other Non-Current Assets
AMLX Non Current Assets Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +466.4% | -83.2% |
3 y3 years | +10000.0% | -83.2% |
5 y5 years | +10000.0% | -83.2% |
AMLX Non Current Assets Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +7862.0% | -89.7% | +722.0% |
5 y | 5-year | at high | >+9999.0% | -89.7% | +1072.0% |
alltime | all time | at high | >+9999.0% | -89.7% | +1072.0% |
Amylyx Pharmaceuticals Non Current Assets History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $5.45 M(+0.2%) |
Jun 2024 | - | $5.44 M(-21.4%) |
Mar 2024 | - | $6.92 M(-86.9%) |
Dec 2023 | $464.67 M(+21.6%) | $52.79 M(+62.6%) |
Sep 2023 | - | $32.47 M(+24.0%) |
Jun 2023 | - | $26.19 M(+38.6%) |
Mar 2023 | - | $18.91 M(+102.8%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2022 | $382.13 M(+264.1%) | $9.32 M(+0.8%) |
Sep 2022 | - | $9.24 M(+1.6%) |
Jun 2022 | - | $9.10 M(+1.7%) |
Mar 2022 | - | $8.95 M(+1249.9%) |
Dec 2021 | $104.95 M(+669.5%) | $663.00 K(+28.0%) |
Sep 2021 | - | $518.00 K(+11.4%) |
Dec 2020 | $13.64 M(+326.0%) | $465.00 K |
Dec 2019 | $3.20 M | - |
FAQ
- What is Amylyx Pharmaceuticals annual long term assets?
- What is the all time high annual non current assets for Amylyx Pharmaceuticals?
- What is Amylyx Pharmaceuticals annual non current assets year-on-year change?
- What is Amylyx Pharmaceuticals quarterly long term assets?
- What is the all time high quarterly non current assets for Amylyx Pharmaceuticals?
- What is Amylyx Pharmaceuticals quarterly non current assets year-on-year change?
What is Amylyx Pharmaceuticals annual long term assets?
The current annual non current assets of AMLX is $52.79 M
What is the all time high annual non current assets for Amylyx Pharmaceuticals?
Amylyx Pharmaceuticals all-time high annual long term assets is $52.79 M
What is Amylyx Pharmaceuticals annual non current assets year-on-year change?
Over the past year, AMLX annual long term assets has changed by +$43.47 M (+466.39%)
What is Amylyx Pharmaceuticals quarterly long term assets?
The current quarterly non current assets of AMLX is $5.45 M
What is the all time high quarterly non current assets for Amylyx Pharmaceuticals?
Amylyx Pharmaceuticals all-time high quarterly long term assets is $52.79 M
What is Amylyx Pharmaceuticals quarterly non current assets year-on-year change?
Over the past year, AMLX quarterly long term assets has changed by -$27.02 M (-83.22%)